Enhancement of Ebola virus infection via ficolin-1 interaction with the mucin domain of GP glycoprotein

Journal of Virology

Volumn 90, Issue 11, 2016, Pages 5256-5269

  Favier, Anne Laure ^a   Gout, Evelyne ^b,c   Reynard, Olivier ^d   Ferraris, Olivier ^a   Kleman, Jean Philippe ^b,c   Volchkov, Viktor ^d   Peyrefitte, Christophe ^a   Thielens, Nicole M ^b,c  

^a INSTITUT DE RECHERCHE BIOMÉDICALE DES ARMÉES   (France)

^b INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^c CEA GRENOBLE   (France)

^d CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; FIBRINOGEN; FICOLIN; FICOLIN 1; MUCIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; LECTIN; MANNOSE BINDING LECTIN; MEMBRANE PROTEIN; PROTEIN BINDING; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE; MONOCYTE DERIVED MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIALYLATION; SURFACE PLASMON RESONANCE; ANIMAL; CELL LINE; CHEMISTRY; CHLOROCEBUS AETHIOPS; GENETICS; HEK293 CELL LINE; METABOLISM; MUTATION; VERO CELL LINE; VIROLOGY; VIRUS ENTRY;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COMPLEMENT SYSTEM PROTEINS; EBOLAVIRUS; HEK293 CELLS; HUMANS; LECTINS; MACROPHAGES; MANNOSE-BINDING LECTIN; MEMBRANE GLYCOPROTEINS; MUCINS; MUTATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84971418668     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00232-16     Document Type: Article

References (83)

1. Feldmann H, Geisbert TW. 2011. Ebola haemorrhagic fever. Lancet 377:849-862. http://dx.doi.org/10.1016/S0140-6736(10)60667-8.
2. Johnson KM, Lange JV, Webb PA, Murphy FA. 1977. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet i:569-571.
3. Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow MS, Keita S, De Clerck H, Tiffany A, Dominguez G, Loua M, Traore A, Kolie M, Malano ER, Heleze E, Bocquin A, Mely S, Raoul H, Caro V, Cadar D, Gabriel M, Pahlmann M, Tappe D, Schmidt-Chanasit J, Impouma B, Diallo AK, Formenty P, Van Herp M, Gunther S. 2014. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 371:1418-1425. http://dx.doi.org/10.1056/NEJMoa1404505.
4. Reynard O, Volchkov V, Peyrefitte C. 2014. A first outbreak of Ebola virus in West Africa. Med Sci (Paris) 30:671-673. (In French.) http://dx.doi.org/10.1051/medsci/20143006018.
5. Wolz A. 2014. Face to face with Ebola-an emergency care center in Sierra Leone. N Engl J Med 371:1801-1803. http://dx.doi.org/10.1056/NEJMp1410179.
6. Gulland A. 2014. Fear spreads as number of Ebola cases in Guinea rises. BMJ 348:g2644. http://dx.doi.org/10.1136/bmj.g2644.
7. Sanchez A, Khan AS, Zaki SR, Nabel GJ, Ksiazek TG, Peters C. 2001. Filorviridae "Marburg and Ebola viruses, " p 1279-1304. In Howley PM, Griffin DE, Lamb RA, Martin MA, Straus SE, Roizman B (ed), Fields virology, 4th ed, vol 1. Lippincott Williams & Wilkins, Philadelphia, PA.
8. Bah A. 2014. Impact de la fièvre Ebola sur l'économie en Guinée: des secteurs fortement touchés. Guinéenews: dernières nouvelles de la Guinée par les Guinéens. http://guineenews.org/impact-de-la-fievre-ebola-sur-leconomie-en-guinee-des-secteurs-fortement-touches/.
9. Ito H, Watanabe S, Takada A, Kawaoka Y. 2001. Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol 75:1576-1580. http://dx.doi.org/10.1128/JVI.75.3.1576-1580.2001.
10. Takada A, Robison C, Goto H, Sanchez A, Murti KG, Whitt MA, Kawaoka Y. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A 94:14764-14769. http://dx.doi.org/10.1073/pnas.94.26.14764.
11. Takada A, Watanabe S, Okazaki K, Kida H, Kawaoka Y. 2001. Infectivity-enhancing antibodies to Ebola virus glycoprotein. J Virol 75:2324-2330. http://dx.doi.org/10.1128/JVI.75.5.2324-2330.2001.
12. Takada A, Kawaoka Y. 2003. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev Med Virol 13:387-398. http://dx.doi.org/10.1002/rmv.405.
13. Feldmann H, Volchkov VE, Volchkova VA, Stroher U, Klenk HD. 2001. Biosynthesis and role of filoviral glycoproteins. J Gen Virol 82:2839-2848. http://dx.doi.org/10.1099/0022-1317-82-12-2839.
14. Volchkov VE, Volchkova VA, Dolnik O, Feldmann H, Klenk HD. 2005. Polymorphism of filovirus glycoproteins. Adv Virus Res 64:359-381. http://dx.doi.org/10.1016/S0065-3527(05)64011-0.
15. Sanchez A, Trappier SG, Mahy BW, Peters CJ, Nichol ST. 1996. The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A 93:3602-3607. http://dx.doi.org/10.1073/pnas.93.8.3602.
16. Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, Vincent MJ, Towner JS, Nichol ST, Bavari S, Choe H, Aman MJ, Farzan M. 2006. Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem 281:15951-15958. http://dx.doi.org/10.1074/jbc.M601796200.
17. Lee JE, Fusco ML, Hessell AJ, Oswald WB, Burton DR, Saphire EO. 2008. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454:177-182. http://dx.doi.org/10.1038/nature07082.
18. Lennemann NJ, Rhein BA, Ndungo E, Chandran K, Qiu X, Maury W. 2014. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. mBio 5:e00862-13. http://dx.doi.org/10.1128/mBio.00862-13.
19. Alvarez CP, Lasala F, Carrillo J, Muniz O, Corbi AL, Delgado R. 2002. C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol 76:6841-6844. http://dx.doi.org/10.1128/JVI.76.13.6841-6844.2002.
20. Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL, Doms RW, Bates P, Pohlmann S. 2003. DC-SIGN and DC-SIGNR bind Ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305:115-123. http://dx.doi.org/10.1006/viro.2002.1730.
21. Lin G, Simmons G, Pohlmann S, Baribaud F, Ni H, Leslie GJ, Haggarty BS, Bates P, Weissman D, Hoxie JA, Doms RW. 2003. Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR. J Virol 77:1337-1346. http://dx.doi.org/10.1128/JVI.77.2.1337-1346.2003.
22. Dominguez-Soto A, Aragoneses-Fenoll L, Martin-Gayo E, Martinez-Prats L, Colmenares M, Naranjo-Gomez M, Borras FE, Munoz P, Zubiaur M, Toribio ML, Delgado R, Corbi AL. 2007. The DC-SIGNrelated lectin LSECtin mediates antigen capture and pathogen binding by human myeloid cells. Blood 109:5337-5345. http://dx.doi.org/10.1182/blood-2006-09-048058.
23. Takada A, Fujioka K, Tsuiji M, Morikawa A, Higashi N, Ebihara H, Kobasa D, Feldmann H, Irimura T, Kawaoka Y. 2004. Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 78:2943-2947. http://dx.doi.org/10.1128/JVI.78.6.2943-2947.2004.
24. Moller-Tank S, Kondratowicz AS, Davey RA, Rennert PD, Maury W. 2013. Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry. J Virol 87:8327-8341. http://dx.doi.org/10.1128/JVI.01025-13.
25. Ji X, Olinger GG, Aris S, Chen Y, Gewurz H, Spear GT. 2005. Mannosebinding lectin binds to Ebola and Marburg envelope glycoproteins, result-ing in blocking of virus interaction with DC-SIGN and complementmediated virus neutralization. J Gen Virol 86:2535-2542. http://dx.doi.org/10.1099/vir.0.81199-0.
26. Michelow IC, Dong M, Mungall BA, Yantosca LM, Lear C, Ji X, Karpel M, Rootes CL, Brudner M, Houen G, Eisen DP, Kinane TB, Takahashi K, Stahl GL, Olinger GG, Spear GT, Ezekowitz RA, Schmidt EV. 2010. A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. J Biol Chem 285:24729-24739. http://dx.doi.org/10.1074/jbc.M110.106260.
27. Jack DL, Klein NJ, Turner MW. 2001. Mannose-binding lectin: targeting the microbial world for complement attack and opsonophagocytosis. Immunol Rev 180:86-99. http://dx.doi.org/10.1034/j.1600-065X.2001.1800108.x.
28. Matsushita M, Fujita T. 2001. Ficolins and the lectin complement pathway. Immunol Rev 180:78-85. http://dx.doi.org/10.1034/j.1600-065X.2001.1800107.x.
29. Petersen SV, Thiel S, Jensenius JC. 2001. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38:133-149. http://dx.doi.org/10.1016/S0161-5890(01)00038-4.
30. Brudner M, Karpel M, Lear C, Chen L, Yantosca LM, Scully C, Sarraju A, Sokolovska A, Zariffard MR, Eisen DP, Mungall BA, Kotton DN, Omari A, Huang IC, Farzan M, Takahashi K, Stuart L, Stahl GL, Ezekowitz AB, Spear GT, Olinger GG, Schmidt EV, Michelow IC. 2013. Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors. PLoS One 8:e60838. http://dx.doi.org/10.1371/journal.pone.0060838.
31. Michelow IC, Lear C, Scully C, Prugar LI, Longley CB, Yantosca LM, Ji X, Karpel M, Brudner M, Takahashi K, Spear GT, Ezekowitz RA, Schmidt EV, Olinger GG. 2011. High-dose mannose-binding lectin therapy for Ebola virus infection. J Infect Dis 203:175-179. http://dx.doi.org/10.1093/infdis/jiq025.
32. Lu J, Teh C, Kishore U, Reid KB. 2002. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim Biophys Acta 1572:387-400. http://dx.doi.org/10.1016/S0304-4165(02)00320-3.
33. Holmskov U, Thiel S, Jensenius JC. 2003. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 21:547-578. http://dx.doi.org/10.1146/annurev.immunol.21.120601.140954.
34. Liu Y, Endo Y, Iwaki D, Nakata M, Matsushita M, Wada I, Inoue K, Munakata M, Fujita T. 2005. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 175:3150-3156. http://dx.doi.org/10.4049/jimmunol.175.5.3150.
35. Garlatti V, Martin L, Lacroix M, Gout E, Arlaud GJ, Thielens NM, Gaboriaud C. 2010. Structural insights into the recognition properties of human ficolins. J Innate Immun 2:17-23. http://dx.doi.org/10.1159/000233475.
36. Thielens NM. 2011. The double life of M-ficolin: what functions when circulating in serum and tethered to leukocyte surfaces? J Leukoc Biol 90:410-412. http://dx.doi.org/10.1189/jlb.0611281.
37. Thiel S. 2007. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol Immunol 44:3875-3888. http://dx.doi.org/10.1016/j.molimm.2007.06.005.
38. Krarup A, Sorensen UB, Matsushita M, Jensenius JC, Thiel S. 2005. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun 73:1052-1060. http://dx.doi.org/10.1128/IAI.73.2.1052-1060.2005.
39. Munthe-Fog L, Hummelshoj T, Hansen BE, Koch C, Madsen HO, Skjodt K, Garred P. 2007. The impact of FCN2 polymorphisms and haplotypes on the ficolin-2 serum levels. Scand J Immunol 65:383-392. http://dx.doi.org/10.1111/j.1365-3083.2007.01915.x.
40. Wittenborn T, Thiel S, Jensen L, Nielsen HJ, Jensenius JC. 2010. Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun 2:167-180. http://dx.doi.org/10.1159/000218324.
41. Chang WC, Hartshorn KL, White MR, Moyo P, Michelow IC, Koziel H, Kinane BT, Schmidt EV, Fujita T, Takahashi K. 2011. Recombinant chimeric lectins consisting of mannose-binding lectin and L-ficolin are potent inhibitors of influenza A virus compared with mannose-binding lectin. Biochem Pharmacol 81:388-395. http://dx.doi.org/10.1016/j.bcp.2010.10.012.
42. Hamed MR, Brown RJ, Zothner C, Urbanowicz RA, Mason CP, Krarup A, McClure CP, Irving WL, Ball JK, Harris M, Hickling TP, Tarr AW. 2014. Recombinant human L-ficolin directly neutralizes hepatitis C virus entry. J Innate Immun 6:676-684. http://dx.doi.org/10.1159/000362209.
43. Verma A, White M, Vathipadiekal V, Tripathi S, Mbianda J, Ieong M, Qi L, Taubenberger JK, Takahashi K, Jensenius JC, Thiel S, Hartshorn KL. 2012. Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses. J Immunol 189:2478-2487. http://dx.doi.org/10.4049/jimmunol.1103786.
44. Pan Q, Chen H, Wang F, Jeza VT, Hou W, Zhao Y, Xiang T, Zhu Y, Endo Y, Fujita T, Zhang XL. 2012. L-ficolin binds to the glycoproteins hemagglutinin and neuraminidase and inhibits influenzaAvirus infection both in vitro and in vivo. J Innate Immun 4:312-324. http://dx.doi.org/10.1159/000335670.
45. Garbutt M, Liebscher R, Wahl-Jensen V, Jones S, Moller P, Wagner R, Volchkov V, Klenk HD, Feldmann H, Stroher U. 2004. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol 78:5458-5465. http://dx.doi.org/10.1128/JVI.78.10.5458-5465.2004.
46. Reynard O, Volchkov VE. 2015. Characterization of a novel neutralizing monoclonal antibody against Ebola virus GP. J Infect Dis 212(Suppl 2): S372-S378. http://dx.doi.org/10.1093/infdis/jiv303.
47. Lacroix M, Dumestre-Perard C, Schoehn G, Houen G, Cesbron JY, Arlaud GJ, Thielens NM. 2009. Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in H-ficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin. J Immunol 182:456-465. http://dx.doi.org/10.4049/jimmunol.182.1.456.
48. Gout E, Garlatti V, Smith DF, Lacroix M, Dumestre-Perard C, Lunardi T, Martin L, Cesbron JY, Arlaud GJ, Gaboriaud C, Thielens NM. 2010. Carbohydrate recognition properties of human ficolins: glycan array screening reveals the sialic acid binding specificity of M-ficolin. J Biol Chem 285:6612-6622. http://dx.doi.org/10.1074/jbc.M109.065854.
49. Jacquet M, Lacroix M, Ancelet S, Gout E, Gaboriaud C, Thielens NM, Rossi V. 2013. Deciphering complement receptor type 1 interactions with recognition proteins of the lectin complement pathway. J Immunol 190: 3721-3731. http://dx.doi.org/10.4049/jimmunol.1202451.
50. Teillet F, Lacroix M, Thiel S, Weilguny D, Agger T, Arlaud GJ, Thielens NM. 2007. Identification of the site of human mannan-binding lectin involved in the interaction with its partner serine proteases: the essential role of Lys55. J Immunol 178:5710-5716. http://dx.doi.org/10.4049/jimmunol.178.9.5710.
51. Garlatti V, Martin L, Gout E, Reiser JB, Fujita T, Arlaud GJ, Thielens NM, Gaboriaud C. 2007. Structural basis for innate immune sensing by M-ficolin and its control by a pH-dependent conformational switch. J Biol Chem 282:35814-35820. http://dx.doi.org/10.1074/jbc.M705741200.
52. Gjelstrup LC, Kaspersen JD, Behrens MA, Pedersen JS, Thiel S, Kingshott P, Oliveira CL, Thielens NM, Vorup-Jensen T. 2012. The role of nanometer-scaled ligand patterns in polyvalent binding by large mannanbinding lectin oligomers. J Immunol 188:1292-1306. http://dx.doi.org/10.4049/jimmunol.1103012.
53. Lee JE, Fusco ML, Abelson DM, Hessell AJ, Burton DR, Saphire EO. 2009. Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein. Acta Crystallogr D Biol Crystallogr 65: 1162-1180. http://dx.doi.org/10.1107/S0907444909032314.
54. Martinez O, Tantral L, Mulherkar N, Chandran K, Basler CF. 2011. Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles. J Infect Dis 204(Suppl 3): S825-S832. http://dx.doi.org/10.1093/infdis/jir295.
55. Yonezawa A, Cavrois M, Greene WC. 2005. Studies of Ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. J Virol 79:918-926. http://dx.doi.org/10.1128/JVI.79.2.918-926.2005.
56. Teh C, Le Y, Lee SH, Lu J. 2000. M-ficolin is expressed on monocytes and is a lectin binding to N-acetyl-D-glucosamine and mediates monocyte adhesion and phagocytosis of Escherichia coli. Immunology 101:225-232. http://dx.doi.org/10.1046/j.1365-2567.2000.00099.x.
57. Frederiksen PD, Thiel S, Larsen CB, Jensenius JC. 2005. M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol 62:462-473. http://dx.doi.org/10.1111/j.1365-3083.2005.01685.x.
58. Geisler C, Jarvis DL. 2012. Innovative use of a bacterial enzyme involved in sialic acid degradation to initiate sialic acid biosynthesis in glycoengi-neered insect cells. Metab Eng 14:642-652. http://dx.doi.org/10.1016/j.ymben.2012.08.005.
59. Kaletsky RL, Simmons G, Bates P. 2007. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol 81:13378-13384. http://dx.doi.org/10.1128/JVI.01170-07.
60. Ballegaard V, Haugaard AK, Garred P, Nielsen SD, Munthe-Fog L. 2014. The lectin pathway of complement: advantage or disadvantage in HIV pathogenesis? Clin Immunol 154:13-25. http://dx.doi.org/10.1016/j.clim.2014.06.002.
61. Kjaer TR, Hansen AG, Sorensen UB, Nielsen O, Thiel S, Jensenius JC. 2011. Investigations on the pattern recognition molecule M-ficolin: quantitative aspects of bacterial binding and leukocyte association. J Leukoc Biol 90:425-437. http://dx.doi.org/10.1189/jlb.0411201.
62. Ritchie G, Harvey DJ, Stroeher U, Feldmann F, Feldmann H, Wahl-Jensen V, Royle L, Dwek RA, Rudd PM. 2010. Identification of Nglycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom 24:571-585. http://dx.doi.org/10.1002/rcm.4410.
63. Olal D, Kuehne AI, Bale S, Halfmann P, Hashiguchi T, Fusco ML, Lee JE, King LB, Kawaoka Y, Dye JM, Jr, Saphire EO. 2012. Structure of an antibody in complex with its mucin domain linear epitope that is protective against Ebola virus. J Virol 86:2809-2816. http://dx.doi.org/10.1128/JVI.05549-11.
64. Moreno-Amaral AN, Gout E, Danella-Polli C, Tabarin F, Lesavre P, Pereira-da-Silva G, Thielens NM, Halbwachs-Mecarelli L. 2012. Mficolin and leukosialin (CD43): new partners in neutrophil adhesion. J Leukoc Biol 91:469-474. http://dx.doi.org/10.1189/jlb.0911460.
65. Henriksen ML, Brandt J, Andrieu JP, Nielsen C, Jensen PH, Holmskov U, Jorgensen TJ, Palarasah Y, Thielens NM, Hansen S. 2013. Heteromeric complexes of native collectin kidney 1 and collectin liver 1 are found in the circulation with MASPs and activate the complement system. J Immunol 191:6117-6127. http://dx.doi.org/10.4049/jimmunol.1302121.
66. Henriksen ML, Brandt J, Iyer SS, Thielens NM, Hansen S. 2013. Characterization of the interaction between collectin 11 (CL-11, CL-K1) and nucleic acids. Mol Immunol 56:757-767. http://dx.doi.org/10.1016/j.molimm.2013.07.011.
67. Selman L, Hansen S. 2012. Structure and function of collectin liver 1 (CL-L1) and collectin 11 (CL-11, CL-K1). Immunobiology 217:851-863. http://dx.doi.org/10.1016/j.imbio.2011.12.008.
68. Jensen PH, Weilguny D, Matthiesen F, McGuire KA, Shi L, Hojrup P. 2005. Characterization of the oligomer structure of recombinant human mannan-binding lectin. J Biol Chem 280:11043-11051. http://dx.doi.org/10.1074/jbc.M412472200.
69. Hummelshoj T, Fog LM, Madsen HO, Sim RB, Garred P. 2008. Comparative study of the human ficolins reveals unique features of ficolin-3 (Hakata antigen). Mol Immunol 45:1623-1632. http://dx.doi.org/10.1016/j.molimm.2007.10.006.
70. Honore C, Rorvig S, Hummelshoj T, Skjoedt MO, Borregaard N, Garred P. 2010. Tethering of ficolin-1 to cell surfaces through recognition of sialic acid by the fibrinogen-like domain. J Leukoc Biol 88:145-158. http://dx.doi.org/10.1189/jlb.1209802.
71. Sui J, Marasco WA. 2002. Evidence against Ebola virus sGP binding to human neutrophils by a specific receptor. Virology 303:9-14. http://dx.doi.org/10.1006/viro.2002.1715.
72. Martinez O, Johnson JC, Honko A, Yen B, Shabman RS, Hensley LE, Olinger GG, Basler CF. 2013. Ebola virus exploits a monocyte differentiation program to promote its entry. J Virol 87:3801-3814. http://dx.doi.org/10.1128/JVI.02695-12.
73. Frankenberger M, Schwaeble W, Ziegler-Heitbrock L. 2008. Expression of M-ficolin in human monocytes and macrophages. Mol Immunol 45: 1424-1430. http://dx.doi.org/10.1016/j.molimm.2007.08.014.
74. Ogden CA, deCathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, Henson PM. 2001. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194:781-795. http://dx.doi.org/10.1084/jem.194.6.781.
75. Zutter MM, Edelson BT. 2007. The alpha2beta1 integrin: a novel collectin/C1q receptor. Immunobiology 212:343-353. http://dx.doi.org/10.1016/j.imbio.2006.11.013.
76. Ghiran I, Tyagi SR, Klickstein LB, Nicholson-Weller A. 2002. Expression and function of C1q receptors and C1q binding proteins at the cell surface. Immunobiology 205:407-420. http://dx.doi.org/10.1078/0171-2985-00142.
77. Takada A. 2012. Filovirus tropism: cellular molecules for viral entry. Front Microbiol 3:34. http://dx.doi.org/10.3389/fmicb.2012.00034.
78. Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y. 2000. Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry. Virology 278:20-26. http://dx.doi.org/10.1006/viro.2000.0601.
79. Reynard O, Borowiak M, Volchkova VA, Delpeut S, Mateo M, Volchkov VE. 2009. Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J Virol 83:9596-9601. http://dx.doi.org/10.1128/JVI.00784-09.
80. Francica JR, Varela-Rohena A, Medvec A, Plesa G, Riley JL, Bates P. 2010. Steric shielding of surface epitopes and impaired immune recognition induced by the Ebola virus glycoprotein. PLoS Pathog 6:e1001098. http://dx.doi.org/10.1371/journal.ppat.1001098.
81. Noyori O, Matsuno K, Kajihara M, Nakayama E, Igarashi M, Kuroda M, Isoda N, Yoshida R, Takada A. 2013. Differential potential for envelope glycoprotein-mediated steric shielding of host cell surface proteins among filoviruses. Virology 446:152-161. http://dx.doi.org/10.1016/j.virol.2013.07.029.
82. Takada A, Feldmann H, Ksiazek TG, Kawaoka Y. 2003. Antibodydependent enhancement of Ebola virus infection. J Virol 77:7539-7544. http://dx.doi.org/10.1128/JVI.77.13.7539-7544.2003.
83. Matsuno K, Nakayama E, Noyori O, Marzi A, Ebihara H, Irimura T, Feldmann H, Takada A. 2010. C-type lectins do not act as functional receptors for filovirus entry into cells. Biochem Biophys Res Commun 403:144-148. http://dx.doi.org/10.1016/j.bbrc.2010.10.136.